Menactra Pricing Will Be In Line With Wyeth's Prevnar, Sanofi-Aventis Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Sanofi-Aventis will price its meningococcal conjugate vaccine Menactra in line with Wyeth's pneumococcal vaccine Prevnar